日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma

对 BRAF V600E/K 突变型晚期或转移性黑色素瘤的 COLUMBUS 研究中生物标志物和治疗结果的探索性分析

Dummer, Reinhard; Deng, Shibing; Xie, Tao; Pathan, Nuzhat; Saffari, Hedieh; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B; Garbe, Claus; Gogas, Helen J; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandala, Mario; Schadendorf, Dirk; Yamazaki, Naoya; Ascierto, Paolo A; Davis, Craig B; Shah, Khyati; Hamilton, Phineas; di Pietro, Alessandra; Flaherty, Keith

Mycophenolate Mofetil for Treatment of Ipilimumab-Induced Colitis in Patients with Metastatic Melanoma

吗替麦考酚酯治疗转移性黑色素瘤患者伊匹木单抗诱发的结肠炎

Naoum, Christina; Winkler, Julia K; Majenka, Pawel; Loquai, Carmen; Brekner, Annika; Fuchß, Milena; Kähler, Katharina C; Petersen, Marilena; Gutzmer, Ralf; von Wasielewski, Imke; Hassel, Jessica C

A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors

一项针对晚期实体瘤的细胞因子编码合成mRNA混合物单药或联合Cemiplimab治疗的I期、首次人体、剂量递增、扩展试验

Bechter, Oliver; Loquai, Carmen; Champiat, Stephane; Baurain, Jean-Francois; Grob, Jean-Jacques; Utikal, Jochen; Rottey, Sylvie; Berrocal, Alfonso; Hassel, Jessica C; Arance, Ana; Sanmamed, Miguel F; Boers-Sonderen, Marye; Gastman, Brian; Gebhardt, Christoffer; Delafontaine, Brant; Sahin, Ugur; Türeci, Özlem; Brueck, Patrick; Abbadessa, Giovanni; Marpadga, Rahul; Lee, Helen; Yang, Yue; Buday, Barbara; Di Genova, Gianfranco; Wang, Hong; Xia, Binfeng; Lee, Joon Sang; Lebbe, Céleste

Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy

将PD-1抑制剂替换为BRAF+MEK抑制剂可提高接受第二疗程辅助黑色素瘤治疗患者的无复发生存期。

Schumann, Katharina; Klespe, Kai Christian; Mauch, Cornelia; Loquai, Carmen; Schultheis, Ulrike; Börger, Sevil; Thiem, Alexander; Emmert, Steffen; Hoellwerth, Magdalena; Kölblinger, Peter; Nguyen, Van Anh; Wanner, Marina; Richtig, Erika; Peitsch, Wiebke K; Harth, Wolfgang; Zenderowski, Veronika; Braun, Andreas Dominik; Mengoni, Miriam; Dummer, Reinhard; Mangana, Johanna; Maul, Lara Valeska; Meiß, Frank; Rappersberger, Klemens; Persa, Oana Diana; Biedermann, Tilo; Posch, Christian

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma

提前终止治疗不会对黑色素瘤辅助免疫疗法的疗效产生负面影响。

Tomsitz, Dirk; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike; Schilling, Bastian; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk; Berking, Carola; Ugurel, Selma; Heinzerling, Lucie

Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg

晚期黑色素瘤患者临终关怀:一项来自前瞻性皮肤癌登记处 ADOReg 的多中心 DeCOG 研究,纳入 1067 例患者。

Forschner, Andrea; Kähler, Katharina C; Gschnell, Martin; Langan, Ewan A; Weishaupt, Carsten; Meiss, Frank; Thoms, Kai-Martin; Wahl, Renate U; Göppner, Daniela; Garzarolli, Marlene; Sachse, Michael; Schlaak, Max; Reitmajer, Markus; Kellner, Ivonne; Gesierich, Anja; Mohr, Peter; Meier, Friedegund; von Wasielewski, Imke; Herbst, Rudolf; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Terheyden, Patrick; Kaatz, Martin; Haferkamp, Sebastian; Leiter, Ulrike; Ugurel, Selma; Weichenthal, Michael; Berking, Carola; Gutzmer, Ralf; Schadendorf, Dirk; Nanz, Lena; Loquai, Carmen

A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma

COLUMBUS 研究第一部分 7 年更新的简明语言摘要:恩考拉非尼和比美替尼治疗 BRAF V600 突变型黑色素瘤患者

Schadendorf, Dirk; Dummer, Reinhard; Flaherty, Keith T; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B; Garbe, Claus; Gogas, Helen J; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Liszkay; Loquai, Carmen; Mandalà, Mario; Yamazaki, Naoya; Queirolo, Paola; Guenzel, Carolin; Polli, Anna; Thakur, Mahgull; di Pietro, Alessandra; Ascierto, Paolo A

Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

出版商更正:辅助性纳武利尤单抗治疗切除术后的 IIB/C 期黑色素瘤:来自随机、3 期 CheckMate 76K 试验的主要结果

Kirkwood, John M; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M; Ascierto, Paolo A; Menzies, Alexander M; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina V

Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

作者更正:辅助性纳武利尤单抗治疗切除术后的 IIB/C 期黑色素瘤:来自随机、3 期 CheckMate 76K 试验的主要结果

Kirkwood, John M; Del Vecchio, Michele; Weber, Jeffrey; Hoeller, Christoph; Grob, Jean-Jacques; Mohr, Peter; Loquai, Carmen; Dutriaux, Caroline; Chiarion-Sileni, Vanna; Mackiewicz, Jacek; Rutkowski, Piotr; Arenberger, Petr; Quereux, Gaelle; Meniawy, Tarek M; Ascierto, Paolo A; Menzies, Alexander M; Durani, Piyush; Lobo, Maurice; Campigotto, Federico; Gastman, Brian; Long, Georgina V

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

严格的监测可以降低免疫检查点抑制剂引起的心脏毒性的死亡率。

Wang, Ying; Ertl, Carolin; Schmitt, Christina; Hammann, Linda; Kramer, Rafaela; Grabmaier, Ulrich; Schöberl, Florian; Anz, David; Piseddu, Ignazio; Pesch, Giulia; Vera, Julio; Froehlich, Waltraud; Weckbach, Ludwig; Tomsitz, Dirk; Loquai, Carmen; Zimmer, Lisa; Mangana, Johanna; Dummer, Reinhard; Gutzmer, Ralf; Klespe, Kai-Christian; Stege, Henner; Meiss, Frank; Thoms, Kai-Martin; Terheyden, Patrick; Bröckelmann, Paul J; Johnson, Douglas B; French, Lars E; Heinzerling, Lucie